Back

Risk of recurrent ischaemic events in ACS patients with baseline LDL-C below guideline-recommended thresholds: insights from the prospective SPUM-ACS study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Prognosis after acute coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Andrea Denegri

University Hospital of Parma, Parma (Italy)

7 More presentations in this session

Presentation thumbnail
1-year outcomes of patients presenting with acute coronary syndromes in Western Cape, South Africa: findings from the PERFUSION ACS registry
Doctor K. Lukhna (Cape Town, ZA)
Abstract Slides Video
Presentation thumbnail
Long-term prognosis after ST-elevation myocardial infarction according to the Canadian Cardiovascular Society classification of tissue injury severity in acute myocardial infarction
Doctor J. Carberry (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
The prognosis of acute myocardial infarction due to stent thrombosis after 2nd generation drug eluting stents era (comparative study with acute myocardial infarction due to plaque rupture or erosion)
Doctor Y. Kirii (Tsu, JP)
Abstract Slides Video
Presentation thumbnail
Clinical profile and prognosis of Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) in patients with previous Acute Coronary Syndrome (ACS)
Doctor N. Gil Mancebo (Getafe, ES)
Abstract Slides Video
Presentation thumbnail
Survival in STEMI in resource limited settings - obstacles and potential solutions. Critical lesson learnt thorough a prospective observational study
Professor J. Gnanaraj (Chennai, IN) Doctor S. Sankar (Chennai, IN)
Abstract Slides Video

Access the full session

Session thumbnail
Prognosis after acute coronary syndromes

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Exploring residual cardiovascular risk beyond LDL cholesterol in patients with acute destabilisation of known significant atherosclerosis
thumbnail
Congress Presentation
Almost 1 in 2 patients with acute coronary syndrome are extremely high-risk and potential candidates for in-hospital triple lipid-lowering therapy: data from the CALLINICUS-Hellas Registry
thumbnail
Congress Presentation
Association of LDL cholesterol levels and all cause mortality in a real world analysis using data from an international network

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources